Are there any predictors of MTX response in progressive pulmonary sarcoidosis?

Conclusion: Defining initial inflammatory status of potential candidates for therapy might be helpful in further therapeutic decisions and enhance prognostication. Goljan Geremek A. et al. Methotrexate as a single agent for treating pulmonary sarcoidosis: a single centre real-life prospective study Pneumonol Alergol Pol, 2014, 82, 518-33.

Source: European Respiratory Journal - October 30, 2015 Category: Respiratory Medicine Authors: Goljan Geremek, A., Bednarek, M., Demkow, U., Puscinska, E., Nowinski, A., Gorecka, D. Tags: 1.13 Clinical Problems - Other Source Type: research